Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and ...

The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release. – We are ...

Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.

American Merck & Co, known in Europe as MSD, has discontinued the development of vibostolimab and favezelimab, two experimental cancer drugs, after their failure in several trials, according to a ...

In 2020, after 26 years at the bottom of the sea, MS Estonia was the subject of a documentary movie which shall throw authorities and common man around the Baltic sea back to square one. The declared ...

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved ...

Oskar Hansson, a professor of neurology at Lund University, will hold the title of Vice President for Neurodegenerative Disease Early Phase Clinical and Imaging Development at the American ...

Hårt kritiserade Millennium skulle införas i Skåne våren 2025. Nu skjuter regionen upp starten av journalsystemet till efter ...

Det danska läkemedelsbolaget Novo Nordisk rasar med 21 procent på Köpenhamnsbörsen efter att bolaget aviserat huvudresultaten ...

Nu tar redaktionen julledigt, men passar på att påminna om några artiklar från hösten som du kanske missade. Vi önskar alla ...